Verdence Capital Advisors LLC Abb Vie Inc. Transaction History

Verdence Capital Advisors LLC

$1.1 Billion
Q2 2024

A detailed history of Verdence Capital Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Verdence Capital Advisors LLC holds 21,162 shares of ABBV stock, worth $4.12 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

21,162

Previous 20,444 3.51%

Holding current value

$4.12 Million

Previous $3.72 Million 2.5%

% of portfolio

0.33%

Previous 0.34%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$154.79 - $180.76 $111,139 - $129,785	718 Added 3.51%	21,162 $3.63 Million
Q1 2024 Apr 25, 2024	SELL	$159.82 - $182.1 $420,326 - $478,923	-2,630 Reduced 11.4%	20,444 $3.72 Million
Q4 2023 Jan 31, 2024	BUY	$137.6 - $154.97 $144,617 - $162,873	1,051 Added 4.77%	23,074 $3.58 Million
Q3 2023 Oct 25, 2023	BUY	$133.59 - $154.65 $483,729 - $559,987	3,621 Added 19.68%	22,023 $3.28 Million
Q2 2023 Jul 28, 2023	SELL	$132.51 - $164.9 $167,095 - $207,938	-1,261 Reduced 6.41%	18,402 $2.48 Million
Q1 2023 Apr 24, 2023	SELL	$144.61 - $166.54 $862,309 - $993,078	-5,963 Reduced 23.27%	19,663 $3.13 Million
Q4 2022 Jan 20, 2023	SELL	$138.31 - $165.87 $51,589 - $61,869	-373 Reduced 1.43%	25,626 $0
Q3 2022 Nov 15, 2022	BUY	$134.21 - $153.93 $111,931 - $128,377	834 Added 3.31%	25,999 $3.49 Million
Q2 2022 Aug 08, 2022	SELL	$137.62 - $174.96 $2.01 Million - $2.56 Million	-14,628 Reduced 36.76%	25,165 $3.85 Million
Q1 2022 May 02, 2022	BUY	$131.98 - $163.75 $144,518 - $179,306	1,095 Added 2.83%	39,793 $6.45 Million
Q4 2021 Jan 26, 2022	BUY	$107.43 - $135.93 $45,013 - $56,954	419 Added 1.09%	38,698 $5.24 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $20,428 - $23,189	192 Added 0.5%	38,279 $4.13 Million
Q2 2021 Aug 06, 2021	BUY	$105.21 - $117.21 $76,908 - $85,680	731 Added 1.96%	38,087 $4.29 Million
Q1 2021 May 11, 2021	SELL	$102.3 - $112.62 $38,464 - $42,345	-376 Reduced 1.0%	37,356 $4.04 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $9,336 - $12,605	116 Added 0.31%	37,732 $4.04 Million
Q3 2020 Nov 09, 2020	SELL	$85.91 - $100.83 $224,998 - $264,073	-2,619 Reduced 6.51%	37,616 $3.3 Million
Q2 2020 Aug 11, 2020	SELL	$73.37 - $98.18 $230,675 - $308,677	-3,144 Reduced 7.25%	40,235 $3.95 Million
Q1 2020 May 13, 2020	BUY	$64.5 - $97.79 $301,279 - $456,777	4,671 Added 12.07%	43,379 $3.31 Million
Q4 2019 Feb 03, 2020	SELL	$72.13 - $90.25 $37,868 - $47,381	-525 Reduced 1.34%	38,708 $3.43 Million
Q3 2019 Mar 06, 2020	BUY	$62.98 - $75.72 $273,837 - $329,230	4,348 Added 12.46%	39,233 $2.97 Million
Q2 2019 Mar 02, 2020	SELL	$65.7 - $83.98 $146,313 - $187,023	-2,227 Reduced 6.0%	34,885 $2.54 Million
Q1 2019 Mar 02, 2020	BUY	$77.14 - $90.79 $384,465 - $452,497	4,984 Added 15.51%	37,112 $2.99 Million
Q4 2018 Feb 25, 2020	BUY	$77.85 - $96.01 $672,624 - $829,526	8,640 Added 36.78%	32,128 $2.96 Million
Q3 2018 Feb 25, 2020	BUY	$88.91 - $98.84 $90,777 - $100,915	1,021 Added 4.54%	23,488 $2.22 Million
Q2 2018 Feb 11, 2020	SELL	$89.78 - $106.23 $987 - $1,168	-11 Reduced 0.05%	22,467 $2.08 Million
Q1 2018 Jan 30, 2020	SELL	$92.01 - $123.21 $784,385 - $1.05 Million	-8,525 Reduced 27.5%	22,478 $2.13 Million
Q4 2017 Jan 30, 2020	BUY	$89.56 - $98.21 $2.78 Million - $3.04 Million	31,003	31,003 $3 Million

Others Institutions Holding ABBV

# of Institutions

3,694

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verdence Capital Advisors LLC with notifications on news.

Account

Verdence Capital Advisors LLC Abb Vie Inc. Transaction History